Telomir Pharmaceuticals, Inc. Common Stock (TELO) Earnings History
Annual and quarterly earnings data from 2021 to 2025
Loading earnings history...
TELO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TELO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export TELO earnings history in CSV or JSON format
Free sign-in required to download data
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Earnings Overview
As of May 7, 2026, Telomir Pharmaceuticals, Inc. Common Stock (TELO) reported trailing twelve-month net income of -$10M, reflecting +41.1% year-over-year growth. The company earned $-0.30 per diluted share over the past four quarters.
Looking at the long-term picture, TELO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$138,131 in fiscal 2021.
Telomir Pharmaceuticals, Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TARA (-$57M net income), ADTX (-$42M net income, -25708.8% margin), AEYE (-$3M net income, -7.6% margin), TELO has comparable earnings metrics. Compare TELO vs TARA →
TELO Earnings vs Peers
Earnings metrics vs comparable public companies
TELO Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$10M | +37.0% | -$11M | $-0.33 | - | - |
| 2024 | -$17M | -26.5% | -$12M | $-0.56 | - | - |
| 2023 | -$13M | -1430.4% | -$4M | $-0.44 | - | - |
| 2022 | $-854,147 | -518.4% | $-854,147 | $-0.03 | - | - |
| 2021 | $-138,131 | - | $-138,131 | $-0.00 | - | - |
See TELO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TELO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TELO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTELO — Frequently Asked Questions
Quick answers to the most common questions about buying TELO stock.
Is TELO growing earnings?
TELO EPS is $-0.30, with earnings growth accelerating to +41.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-10M.
What are TELO's profit margins?
Telomir Pharmaceuticals, Inc. Common Stock net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are TELO's earnings?
TELO earnings data spans 2021-2025. The accelerating earnings trend is +41.1% YoY. Historical data enables comparison across business cycles.